iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells. (2022)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/jcs.259949
PubMed Identifier: 35971826
Publication URI: http://europepmc.org/abstract/MED/35971826
Type: Journal Article/Review
Volume: 135
Parent Publication: Journal of cell science
Issue: 17
ISSN: 0021-9533